- Home
- ESNT vs VANI Comparison
ESNT vs VANI Comparison
Compare ESNT & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESNT | VANI |
|---|---|---|
| Founded | 2008 | 1998 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 81.2M |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ESNT | VANI |
|---|---|---|
| Price | $65.25 | $1.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $66.80 | $4.00 |
| AVG Volume (30 Days) | ★ 584.9K | 173.2K |
| Earning Date | 11-07-2025 | 11-13-2025 |
| Dividend Yield | ★ 1.93% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.87 | N/A |
| Revenue | ★ $1,263,558,000.00 | N/A |
| Revenue This Year | $3.87 | N/A |
| Revenue Next Year | $1.55 | N/A |
| P/E Ratio | $9.37 | ★ N/A |
| Revenue Growth | ★ 2.04 | N/A |
| 52 Week Low | $51.61 | $0.91 |
| 52 Week High | $65.90 | $1.92 |
Technical Indicators
Market Signals| Indicator | ESNT | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 69.36 | 45.64 |
| Support Level | $61.25 | $1.25 |
| Resistance Level | $62.35 | $1.55 |
| Average True Range (ATR) | 1.03 | 0.07 |
| MACD | 0.28 | 0.00 |
| Stochastic Oscillator | 91.95 | 40.07 |
Price Performance
Historical ComparisonAbout ESNT Essent Group Ltd.
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.